Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study
This study provides insight into TNBC in Brazil's public health system, showing that OS decreases with disease progression but is higher among Black patients. pCR and adjuvant therapy improve survival, although costs increase significantly at advanced stages, highlighting the economic burden of late-stage TNBC management.
Authors
- Marina Diógenes Teixeira (ORCID: https://orcid.org/0009-0001-7516-0215)
- Fabrício Palermo Brenelli (ORCID: https://orcid.org/0000-0003-0589-1423)
- Luíz Henrique Gebrim (ORCID: https://orcid.org/0000-0001-9941-9191)
- Felipe Zerwes (ORCID: https://orcid.org/0000-0002-1643-727X)
- Renata Arakelian (ORCID: https://orcid.org/0000-0002-6216-6327)
- Ricardo B. Leite (ORCID: https://orcid.org/0000-0002-9622-3895)
- Marcelo Antonini (ORCID: https://orcid.org/0000-0002-1996-7428)
- Antônio Luiz Frasson (ORCID: https://orcid.org/0000-0003-1860-6898)
- Francisco Pimentel Cavalcante (ORCID: https://orcid.org/0000-0002-7156-2890)
- André P. L. Mattar (ORCID: https://orcid.org/0000-0001-5973-623X)
- Cristiano Augusto Andrade de Resende (ORCID: https://orcid.org/0000-0002-9358-7693)
- Eduardo Camargo Millen (ORCID: https://orcid.org/0000-0002-2113-6324)
- Andressa Gonçalves Amorim (ORCID: https://orcid.org/0000-0002-3077-5873)
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Hospital Israelita Albert Einstein (BR)
- Beneficência Portuguesa de São Paulo (BR)
- Hospital do Servidor Público Estadual (BR)
- Sociedade Brasileira de Oncologia Clínica (BR)
- Hospital Geral de Fortaleza (BR)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1200/go-24-00340
- Citations
- 5
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 9.09